NOTICE OF ALLOWANCE - ISSUED
issued
on 26 Nov 2024
Last Applicant/ Owned by
One Kendall Square
Cambridge
MA
02139
Serial Number
98248592 filed on 31st Oct 2023
Registration Number
N/A
Correspondent Address
Christina Licursi
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
SYNTEIN
Pharmaceutical, medical, scientific, and biopharmaceutical research and development; research and development of new products in the fields of proteins and peptides; scientific and medical research in the field of proteins and peptides; scientific and engineering research services relating to synthetic biology, genetic engineering, biotechnology and biological engineering; computer-aided design of Read More
Classification Information
Class [042]
Computer & Software Services & Scientific Services
Pharmaceutical, medical, scientific, and biopharmaceutical research and development; research and development of new products in the fields of proteins and peptides; scientific and medical research in the field of proteins and peptides; scientific and engineering research services relating to synthetic biology, genetic engineering, biotechnology and biological engineering; computer-aided design of genetically engineered proteins and peptides; computer-aided design of engineered proteins and peptides
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [040]
Treatment & Processing of Materials Services
Custom manufacturing of genetically engineered proteins and peptides; custom manufacturing of engineered proteins and peptides; custom manufacturing and custom synthesis of engineered proteins and peptides for scientific, engineering, research, and medical use
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [001]
Chemical Products
Proteins for use in manufacture; synthetic proteins and synthetic peptides, in raw material form, for scientific and medical research; synthetic proteins and synthetic peptides for medical diagnostic purposes; synthetic proteins and synthetic peptides for treating viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; biomedical compounds, namely, peptide substrates used in analyzing and detecting certain toxins for clinical or medical laboratory use
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 98248592
Mark Type
No Service/Collective Mark
Attorney Docket Number
No F08762000600
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 26th Nov 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| 25th Nov 2024 | CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED |
| 18th Nov 2024 | ASSIGNED TO PETITION STAFF |
| 24th Oct 2024 | TEAS POST PUBLICATION AMENDMENT RECEIVED |
| 15th Oct 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 15th Oct 2024 | PUBLISHED FOR OPPOSITION |
| 25th Sep 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 11th Sep 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 06th Sep 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 06th Sep 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |